: Management explanation and analysis Quarter 3/2020 ending 30 September 2020 Attention: The President of, The Stock Exchange of Thailand Ziga Innovation Public Company Limited (“the Company”) manufactures and
April 27th, 2021 No. ACC/HO 008/64 Topic: Management Discussion and Analysis for the Quarter of 1/2021 To: President The Stock Exchange of Thailand During the first quarter of 2021 a new wave of
Microsoft Word - MD&A-E-mh-FA-nn.docx 1 Ref: CSO 016/2020 Date: 7th May 2020 Subject: Management Discussion and Analysis Quarter 1 Ending 31st March 2020 Attention: President The Stock Exchange of
Ref. No. IVL 002/05/2020 12 May 2020 The President The Stock Exchange of Thailand Subject: Submission of Quarterly Review of Financial Statements and the Management Discussion and Analysis of
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
Discussion and Analysis Quarterly Ending September 30, 2020 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited ( the Company) No. 5
-9320 1 Ref: PCL 2020/018 November 14, 2020 Subject: Management Discussion and Analysis for the 9-month period ended 30 September 2020 To: The President of the Stock Exchange of Thailand Panjawattana
Page 1 No. CMC Sor Lor.012/2019 August 13, 2019 Re: Management Discussion & Analysis for the Period Ended 30 June 2019 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN
Microsoft Word - MD&A-3Q2019-E FA V25Oct2019.docx 1 Ref: CSO. 026/2019 Date: 5th November 2019 Subject: Management Discussion and Analysis Quarter 3 Ending 30th September 2019 Attention: President
Discussion and Analysis Quarterly Ending September 30, 2019 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4